S241656 + PEMBROLIZUMAB

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

S241656 + PEMBROLIZUMAB
Treatment and conditionWhere it standsTrials
S241656 + PEMBROLIZUMAB for histiocytosisPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1